Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 29, 2010 08:30 ET | Source: Icagen, Inc.

Icagen -- Pfizer Pain Collaboration Reaches First-in-Man Milestones

RESEARCH TRIANGLE PARK, N.C., July 29, 2010 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today provided an update on its sodium channel program for pain and related disorders, which is being...
June 24, 2010 08:00 ET | Source: Icagen, Inc.

AGTC and Icagen Announce Technology Transfer Agreement

ALACHUA, Fla. and RESEARCH TRIANGLE PARK, N.C., June 24, 2010 (GLOBE NEWSWIRE) -- AGTC, a privately held company, and Icagen, Inc. (Nasdaq:ICGN) today announced the completion of an agreement for the...
May 07, 2010 08:30 ET | Source: Icagen, Inc.

Icagen Reports First Quarter 2010 Financial Results and Operational Highlights

RESEARCH TRIANGLE PARK, N.C., May 7, 2010 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) reported today its financial results and operational highlights for the first quarter ended March 31, 2010. For...
April 28, 2010 08:30 ET | Source: Icagen, Inc.

Icagen to Report First Quarter 2010 Results on May 7, 2010

RESEARCH TRIANGLE PARK, N.C., April 28, 2010 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced plans to release first quarter 2010 financial results on Friday, May 7, 2010 before the...
April 27, 2010 08:35 ET | Source: Icagen, Inc.

Icagen Provides Update Regarding Clinical Development Plans for ICA-105665

RESEARCH TRIANGLE PARK, N.C., April 27, 2010 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today provided an update on clinical development plans for ICA-105665, the Company's novel drug candidate...
April 21, 2010 08:30 ET | Source: Icagen, Inc.

ICA-105665 Phase IIa Epilepsy Data to be Presented at the Tenth Eilat Conference on New Antiepileptic Drugs

RESEARCH TRIANGLE PARK, N.C., April 21, 2010 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced that results from a study of ICA-105665 in patients with photosensitive epilepsy will be...
March 30, 2010 08:30 ET | Source: Icagen, Inc.

Icagen Reports Fourth Quarter and Full Year 2009 Financial Results and Operational Highlights

RESEARCH TRIANGLE PARK, N.C., March 30, 2010 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) reported today its financial results and operational highlights for the fourth quarter and full year ended...
March 18, 2010 08:30 ET | Source: Icagen, Inc.

Icagen to Announce Fourth Quarter and Full Year 2009 Results and Conduct Conference Call on March 30, 2010

RESEARCH TRIANGLE PARK, N.C., March 18, 2010 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced it will release financial results for the fourth quarter and full year 2009 on Tuesday,...
March 15, 2010 17:00 ET | Source: Icagen, Inc.

Icagen Reports Positive Results for ICA-105665 in Patients With Photosensitive Epilepsy

RESEARCH TRIANGLE PARK, N.C., March 15, 2010 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today reported positive results in its Phase IIa epilepsy study of ICA-105665, the Company's novel orally...
March 01, 2010 16:30 ET | Source: Icagen, Inc.

Icagen Reports Results of Phase Ib Pain Study of ICA-105665

RESEARCH TRIANGLE PARK, N.C., March 1, 2010 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today reported results of its Phase Ib pain study of ICA-105665, the Company's novel orally available small...